These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31778882)

  • 1. Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs).
    Chandler M; Johnson MB; Panigaj M; Afonin KA
    Curr Opin Biotechnol; 2020 Jun; 63():8-15. PubMed ID: 31778882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells.
    Bila D; Radwan Y; Dobrovolskaia MA; Panigaj M; Afonin KA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles.
    Hong E; Halman JR; Shah AB; Khisamutdinov EF; Dobrovolskaia MA; Afonin KA
    Nano Lett; 2018 Jul; 18(7):4309-4321. PubMed ID: 29894623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.
    Johnson MB; Chandler M; Afonin KA
    Adv Drug Deliv Rev; 2021 Jun; 173():427-438. PubMed ID: 33857556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating Immunorecognition Pathways Activated by RNA Nanostructures.
    Danai L; Johnson MB; Afonin KA
    Methods Mol Biol; 2023; 2709():229-240. PubMed ID: 37572284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior.
    Chandler M; Afonin KA
    Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 31013847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification.
    Johnson MB; Halman JR; Miller DK; Cooper JS; Khisamutdinov EF; Marriott I; Afonin KA
    Nucleic Acids Res; 2020 Nov; 48(20):11785-11798. PubMed ID: 33091133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Intracellular Compartmentalization of RNA Nanostructures.
    Radwan Y; Afonin KA; Johnson MB
    Methods Mol Biol; 2023; 2709():211-228. PubMed ID: 37572283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells.
    Hong E; Halman JR; Shah A; Cedrone E; Truong N; Afonin KA; Dobrovolskaia MA
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.
    Avila YI; Chandler M; Cedrone E; Newton HS; Richardson M; Xu J; Clogston JD; Liptrott NJ; Afonin KA; Dobrovolskaia MA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles.
    Panigaj M; Skelly E; Beasock D; Marriott I; Johnson MB; Salotti J; Afonin KA
    Front Immunol; 2023; 14():1053550. PubMed ID: 36798121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Break to Build: Isothermal Assembly of Nucleic Acid Nanoparticles (NANPs)
    Beasock D; Ha A; Halman J; Panigaj M; Wang J; Dokholyan NV; Afonin KA
    Bioconjug Chem; 2023 Jun; 34(6):1139-1146. PubMed ID: 37293781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting Functional Biological Interactions Using Modular RNA Nanoparticles.
    Klotz K; Radwan Y; Chakrabarti K
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Immune Cell, AI-cell, a New Tool to Predict Interferon Production by Peripheral Blood Monocytes in Response to Nucleic Acid Nanoparticles.
    Chandler M; Jain S; Halman J; Hong E; Dobrovolskaia MA; Zakharov AV; Afonin KA
    Small; 2022 Nov; 18(46):e2204941. PubMed ID: 36216772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure-Activity Relationship and Mechanistic Insights.
    Rebolledo LP; Ke W; Cedrone E; Wang J; Majithia K; Johnson MB; Dokholyan NV; Dobrovolskaia MA; Afonin KA
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8430-8441. PubMed ID: 38344840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution.
    Halman JR; Kim KT; Gwak SJ; Pace R; Johnson MB; Chandler MR; Rackley L; Viard M; Marriott I; Lee JS; Afonin KA
    Nanomedicine; 2020 Jan; 23():102094. PubMed ID: 31669854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating Immune Response with Nucleic Acid Nanoparticles.
    Durbin JK; Miller DK; Niekamp J; Khisamutdinov EF
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhydrous Nucleic Acid Nanoparticles for Storage and Handling at Broad Range of Temperatures.
    Tran AN; Chandler M; Halman J; Beasock D; Fessler A; McKeough RQ; Lam PA; Furr DP; Wang J; Cedrone E; Dobrovolskaia MA; Dokholyan NV; Trammell SR; Afonin KA
    Small; 2022 Apr; 18(13):e2104814. PubMed ID: 35128787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome mediated delivery of functional nucleic acid nanoparticles (NANPs).
    Nordmeier S; Ke W; Afonin KA; Portnoy V
    Nanomedicine; 2020 Nov; 30():102285. PubMed ID: 32781137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.